Novasenta
Pittsburgh
About Novasenta
Novasenta develops treatments to transform the lives of patients with cancer. It uses systematic, rigorous, and unbiased human tumor microenvironment analysis to uncover new druggable targets, exploiting the critical interplay of disease, immune response, and metabolism. Single-cell level analysis of high-quality, human tumor samples combined with the advanced data mining abilities of our research and computational biology teams accelerate the path from discovery to patient. The company aims to identify novel targets to generate effective therapies for various cancers. It was founded in 2018 and is headquartered in Pittsburgh, Pennsylvania.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $55.0M
- Last round: Series Unknown (Feb 2024)
- Website: novasenta.com
- Phone: 412-621-6200
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/novasenta-64883 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.